{"entity":{"type":"insider","cik":"0001295787","url":"/insider/0001295787","json_url":"/insider/0001295787.json","name":"Arnold Stephen D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":81,"n_filings":20,"first":"2004-07-06","last":"2005-02-24","span_basis":"filed_date"},"name_variants":[{"name":"Arnold Stephen D","source":"filing","n_filings":20,"first_seen":"2004-07-06","last_seen":"2005-02-24"}],"transactions":[{"id":1400859,"accession":"0001209191-05-012048","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-012048","line_url":"/filing/0001209191-05-012048","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; Flint Jonathan A; POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS III LP; MCGUIRE TERRANCE","owner_display_name":"Arnold Stephen D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":7.02,"price_display":"7.02","price_state":"stated","total_value":1755000.0,"total_display":"1,755,000.00","total_whole":"1,755,000","shares_owned_after":4622866.0,"shares_owned_after_display":"4,622,866","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-02-22","filed_date":"2005-02-24","scope":"insider","n_lines":3},{"id":1313473,"accession":"0001209191-05-007079","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-007079","line_url":"/filing/0001209191-05-007079","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; MCGUIRE TERRANCE; POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS III LP; Flint Jonathan A; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; Arnold Stephen D; SPOON ALAN G","owner_display_name":"POLARIS VENTURE PARTNERS FOUNDERS FUND III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85000.0,"shares_display":"85,000","price_per_share":7.41,"price_display":"7.41","price_state":"stated","total_value":629850.0,"total_display":"629,850.00","total_whole":"629,850","shares_owned_after":1938532.0,"shares_owned_after_display":"1,938,532","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-02-02","filed_date":"2005-02-04","scope":"insider","n_lines":3},{"id":1634347,"accession":"0001209191-05-006361","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-05-006361","line_url":"/filing/0001209191-05-006361","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"POLARIS VENTURE PARTNERS III LP; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE MANAGEMENT CO III LLC; MCGUIRE TERRANCE; Flint Jonathan A; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP","owner_display_name":"POLARIS VENTURE PARTNERS III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":7.18,"price_display":"7.18","price_state":"stated","total_value":287200.0,"total_display":"287,200.00","total_whole":"287,200","shares_owned_after":2020179.0,"shares_owned_after_display":"2,020,179","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-02-01","filed_date":"2005-02-02","scope":"insider","n_lines":3},{"id":1634344,"accession":"0001209191-05-006361","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-006361","line_url":"/filing/0001209191-05-006361","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"POLARIS VENTURE PARTNERS III LP; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE MANAGEMENT CO III LLC; MCGUIRE TERRANCE; Flint Jonathan A; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP","owner_display_name":"POLARIS VENTURE PARTNERS III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":168000.0,"total_display":"168,000.00","total_whole":"168,000","shares_owned_after":2058601.0,"shares_owned_after_display":"2,058,601","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-31","filed_date":"2005-02-02","scope":"insider","n_lines":3},{"id":1380285,"accession":"0001209191-05-005203","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-05-005203","line_url":"/filing/0001209191-05-005203","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; Flint Jonathan A; POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS III LP; MCGUIRE TERRANCE","owner_display_name":"Arnold Stephen D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":7.09,"price_display":"7.09","price_state":"stated","total_value":141800.0,"total_display":"141,800.00","total_whole":"141,800","shares_owned_after":2081654.0,"shares_owned_after_display":"2,081,654","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-26","filed_date":"2005-01-27","scope":"insider","n_lines":3},{"id":1380282,"accession":"0001209191-05-005203","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-005203","line_url":"/filing/0001209191-05-005203","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; Flint Jonathan A; POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS III LP; MCGUIRE TERRANCE","owner_display_name":"Arnold Stephen D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":7.16,"price_display":"7.16","price_state":"stated","total_value":143200.0,"total_display":"143,200.00","total_whole":"143,200","shares_owned_after":2100865.0,"shares_owned_after_display":"2,100,865","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-25","filed_date":"2005-01-27","scope":"insider","n_lines":3},{"id":1430500,"accession":"0001209191-05-004724","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-004724","line_url":"/filing/0001209191-05-004724","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"MCGUIRE TERRANCE; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; Flint Jonathan A; Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; POLARIS VENTURE PARTNERS III LP","owner_display_name":"MCGUIRE TERRANCE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22799.0,"shares_display":"22,799","price_per_share":7.58,"price_display":"7.58","price_state":"stated","total_value":172816.42,"total_display":"172,816.42","total_whole":"172,816","shares_owned_after":2102111.0,"shares_owned_after_display":"2,102,111","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-21","filed_date":"2005-01-25","scope":"insider","n_lines":3},{"id":1535215,"accession":"0001209191-05-004199","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-05-004199","line_url":"/filing/0001209191-05-004199","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"MCGUIRE TERRANCE; Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; Flint Jonathan A; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; POLARIS VENTURE PARTNERS III LP; POLARIS VENTURE MANAGEMENT CO III LLC","owner_display_name":"MCGUIRE TERRANCE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":7.63,"price_display":"7.63","price_state":"stated","total_value":64855.0,"total_display":"64,855.00","total_whole":"64,855","shares_owned_after":2124009.0,"shares_owned_after_display":"2,124,009","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-20","filed_date":"2005-01-21","scope":"insider","n_lines":3},{"id":1535212,"accession":"0001209191-05-004199","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-004199","line_url":"/filing/0001209191-05-004199","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"MCGUIRE TERRANCE; Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; Flint Jonathan A; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; POLARIS VENTURE PARTNERS III LP; POLARIS VENTURE MANAGEMENT CO III LLC","owner_display_name":"MCGUIRE TERRANCE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":7.74,"price_display":"7.74","price_state":"stated","total_value":387000.0,"total_display":"387,000.00","total_whole":"387,000","shares_owned_after":2132174.0,"shares_owned_after_display":"2,132,174","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-19","filed_date":"2005-01-21","scope":"insider","n_lines":3},{"id":1503097,"accession":"0001209191-05-003713","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-05-003713","line_url":"/filing/0001209191-05-003713","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"MCGUIRE TERRANCE; Flint Jonathan A; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS III LP; Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP","owner_display_name":"MCGUIRE TERRANCE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":8.54,"price_display":"8.54","price_state":"stated","total_value":93940.0,"total_display":"93,940.00","total_whole":"93,940","shares_owned_after":2180202.0,"shares_owned_after_display":"2,180,202","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-18","filed_date":"2005-01-19","scope":"insider","n_lines":3},{"id":1503094,"accession":"0001209191-05-003713","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-003713","line_url":"/filing/0001209191-05-003713","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"MCGUIRE TERRANCE; Flint Jonathan A; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS III LP; Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP","owner_display_name":"MCGUIRE TERRANCE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13700.0,"shares_display":"13,700","price_per_share":8.77,"price_display":"8.77","price_state":"stated","total_value":120149.0,"total_display":"120,149.00","total_whole":"120,149","shares_owned_after":2190768.0,"shares_owned_after_display":"2,190,768","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-14","filed_date":"2005-01-19","scope":"insider","n_lines":3},{"id":1634313,"accession":"0001209191-05-002595","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-002595","line_url":"/filing/0001209191-05-002595","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"Flint Jonathan A; MCGUIRE TERRANCE; POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS III LP; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP","owner_display_name":"Flint Jonathan A","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":8.3,"price_display":"8.30","price_state":"stated","total_value":207500.0,"total_display":"207,500.00","total_whole":"207,500","shares_owned_after":2203928.0,"shares_owned_after_display":"2,203,928","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-06","filed_date":"2005-01-10","scope":"insider","n_lines":3},{"id":1565111,"accession":"0001209191-05-002192","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-002192","line_url":"/filing/0001209191-05-002192","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS III LP; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; Flint Jonathan A; MCGUIRE TERRANCE; Arnold Stephen D; SPOON ALAN G","owner_display_name":"POLARIS VENTURE MANAGEMENT CO III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46500.0,"shares_display":"46,500","price_per_share":7.68,"price_display":"7.68","price_state":"stated","total_value":357120.0,"total_display":"357,120.00","total_whole":"357,120","shares_owned_after":2227942.0,"shares_owned_after_display":"2,227,942","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-04","filed_date":"2005-01-06","scope":"insider","n_lines":3},{"id":1621292,"accession":"0001209191-05-001012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-001012","line_url":"/filing/0001209191-05-001012","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"POLARIS VENTURE PARTNERS III LP; POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; Arnold Stephen D; SPOON ALAN G; MCGUIRE TERRANCE; Flint Jonathan A; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP","owner_display_name":"POLARIS VENTURE PARTNERS III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":7.63,"price_display":"7.63","price_state":"stated","total_value":381500.0,"total_display":"381,500.00","total_whole":"381,500","shares_owned_after":2272607.0,"shares_owned_after_display":"2,272,607","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-03","filed_date":"2005-01-04","scope":"insider","n_lines":3},{"id":614937,"accession":"0001209191-04-059949","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-04-059949","line_url":"/filing/0001209191-04-059949","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; Arnold Stephen D; SPOON ALAN G; Flint Jonathan A; POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; POLARIS VENTURE PARTNERS III LP; MCGUIRE TERRANCE","owner_display_name":"POLARIS VENTURE PARTNERS FOUNDERS FUND III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6001.0,"shares_display":"6,001","price_per_share":7.56,"price_display":"7.56","price_state":"stated","total_value":45367.56,"total_display":"45,367.56","total_whole":"45,368","shares_owned_after":2320635.0,"shares_owned_after_display":"2,320,635","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-29","filed_date":"2004-12-30","scope":"insider","n_lines":3},{"id":614934,"accession":"0001209191-04-059949","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-04-059949","line_url":"/filing/0001209191-04-059949","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; Arnold Stephen D; SPOON ALAN G; Flint Jonathan A; POLARIS VENTURE MANAGEMENT CO III LLC; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; POLARIS VENTURE PARTNERS III LP; MCGUIRE TERRANCE","owner_display_name":"POLARIS VENTURE PARTNERS FOUNDERS FUND III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":7.56,"price_display":"7.56","price_state":"stated","total_value":49140.0,"total_display":"49,140.00","total_whole":"49,140","shares_owned_after":2326399.0,"shares_owned_after_display":"2,326,399","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-28","filed_date":"2004-12-30","scope":"insider","n_lines":3},{"id":640043,"accession":"0001104659-04-040714","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-04-040714","line_url":"/filing/0001104659-04-040714#line-3","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; Flint Jonathan A; MCGUIRE TERRANCE; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; POLARIS VENTURE PARTNERS III LP; POLARIS VENTURE MANAGEMENT CO III LLC","owner_display_name":"Arnold Stephen D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25455.0,"shares_display":"25,455","price_per_share":6.693,"price_display":"6.69","price_state":"stated","total_value":170370.315,"total_display":"170,370.32","total_whole":"170,370","shares_owned_after":2332643.0,"shares_owned_after_display":"2,332,643","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-17","filed_date":"2004-12-21","scope":"insider"},{"id":640042,"accession":"0001104659-04-040714","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-04-040714","line_url":"/filing/0001104659-04-040714#line-2","is_derivative":false,"issuer_cik":"0001018394","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001018394","owner_cik":null,"owner_name":"Arnold Stephen D; SPOON ALAN G; POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP; Flint Jonathan A; MCGUIRE TERRANCE; POLARIS VENTURE PARTNERS FOUNDERS FUND III LP; POLARIS VENTURE PARTNERS III LP; POLARIS VENTURE MANAGEMENT CO III LLC","owner_display_name":"Arnold Stephen D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650.0,"shares_display":"650","price_per_share":6.693,"price_display":"6.69","price_state":"stated","total_value":4350.45,"total_display":"4,350.45","total_whole":"4,350","shares_owned_after":60601.0,"shares_owned_after_display":"60,601","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-17","filed_date":"2004-12-21","scope":"insider"}],"collapsed":true,"next_cursor":"2004-12-17|640042","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Ten percent owner","n_filings":16,"first_seen":"2004-12-07","last_seen":"2005-02-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001235010","name":"MOMENTA PHARMACEUTICALS INC","url":"/issuer/0001235010","role":"Ten percent owner","n_filings":2,"first_seen":"2004-07-06","last_seen":"2005-02-24"},{"type":"issuer","type_label":"ISSUER","cik":"0000931015","name":"POLARIS INDUSTRIES INC/MN","url":"/issuer/0000931015","role":"Ten percent owner","n_filings":2,"first_seen":"2004-12-14","last_seen":"2004-12-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001295787","retrieved_at":"2026-08-26T19:25:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}